Karim J. Halazun

About

Karim J. Halazun, MD, is a Professor in the Department of Surgery at NYU Grossman School of Medicine and serves as the Section Chief of Hepatobiliary Surgery within the Division of Hepatobiliary and Pancreatic Surgery. He is also the Surgical Director of the Adult Liver Transplant Program at NYU Langone Health. Dr. Halazun's medical background includes an MD from Leeds University obtained in 2002, a residency in Surgery at NY Presbyterian - Columbia University Medical Center completed in 2011, and a fellowship in Transplant Surgery at the same institution completed in 2013. His professional focus is on treating patients with liver cancers, liver failure, and performing complex liver surgeries, including liver transplantation, liver resection, and minimally invasive robotic liver surgery. He has a particular interest in advanced liver surgery, biliary surgery, and liver transplantation, including living donor transplants. Dr. Halazun's work is characterized by a commitment to providing innovative, personalized care through multidisciplinary teams, with a focus on treating conditions such as hepatocellular carcinoma, cholangiocarcinoma, metastases to the liver, and other liver-related diseases. He is dedicated to utilizing the latest surgical techniques, including robotic approaches, to improve patient outcomes and reduce hospital stays.

Research topics

• Oncology
• Internal medicine
• Medicine
• Gastroenterology

Selected publications

• Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma

  JAMA Surgery · 2022-11-23 · 138 citations

  articleOpen access

  Importance: Long-term oncologic outcomes of robotic surgery remain a hotly debated topic in surgical oncology, but sparse data have been published thus far. Objective: To analyze short- and long-term outcomes of robotic liver resection (RLR) for hepatocellular carcinoma (HCC) from Western high-volume centers to assess the safety, reproducibility, and oncologic efficacy of this technique. Design, Setting, and Participants: This cohort study evaluated the outcomes of patients receiving RLR vs open…

  PublisherOA PDFDOI

• Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy

  Transplantation · 2024-03-29 · 10 citations

  articleOpen access

  BACKGROUND: Since February 2020, exception points have been allocated equivalent to the median model for end-stage liver disease at transplant within 250 nautical miles of the transplant center (MMaT/250). We compared transplant rate and waitlist mortality for hepatocellular carcinoma (HCC) exception, non-HCC exception, and non-exception candidates to determine whether MMaT/250 advantages (or disadvantages) exception candidates. METHODS: Using Scientific Registry of Transplant Recipients data, w…

  PublisherOA PDFDOI

• Liver transplantation as a treatment for cancer: comprehensive review

  BJS Open · 2025-05-07 · 7 citations

  reviewOpen access

  BACKGROUND: Liver transplantation for cancer indications has gained momentum in recent years. This review is intended to optimize the care setting of liver transplant candidates by highlighting current indications, technical aspects and barriers with available solutions to facilitate the guidance of available strategies for healthcare professionals in specialized centres. METHODS: A review of the most recent relevant literature was conducted for all the cancer indications of liver transplantatio…

  PublisherOA PDFDOI

• Development and Validation of a Pre-Transplant Risk Score (LT-MVI Score) to Predict Microvascular Invasion in Hepatocellular Carcinoma Candidates for Liver Transplantation

  Cancers · 2025-04-24 · 1 citations

  articleOpen access

  Background/Objectives: MVI is a relevant prognostic factor among patients with hepatocellular carcinoma (HCC) receiving liver transplantation (LT). The preoperative assessment of the risk for MVI is relevant to pre-LT patient management and selection. The objective of this study was to create and validate a model to predict microvascular invasion (MVI) based on preoperative variables in the LT setting. Methods: A total of 2170 patients from 11 collaborative centers in Europe, Asia, and the US, w…

  PublisherOA PDFDOI

• Minimally invasive tools are necessary for the modern practice of liver surgery

  Journal of Minimal Access Surgery · 2024-07-01 · 1 citations

  articleOpen access

  INTRODUCTION: Minimally invasive liver resection (MILR) is performed for other gastrointestinal applications. At our centre, all liver resections are systematically performed using a minimally invasive approach. This study aimed to describe our experience in minimising open surgery and emphasised the importance of minimally invasive surgery. PATIENTS AND METHODS: We retrospectively reviewed 260 patients who underwent liver surgery and compared the surgical outcomes between the open and MILR grou…

  PublisherDOI

Frequent coauthors

• Jean C. Emond

  NewYork–Presbyterian Hospital

  182 shared

• Robert S. Brown

  Weill Cornell Medicine

  116 shared

• Benjamin Samstein

  115 shared

• Russell Rosenblatt

  Weill Cornell Medicine

  97 shared

• Parissa Tabrizian

  Icahn School of Medicine at Mount Sinai

  81 shared

• Adam Griesemer

  Miami Transplant Institute

  79 shared

• Abbas Rana

  Baylor College of Medicine

  76 shared

• Vatche G. Agopian

  76 shared

Similar researchers at New York University

• Jonathan C. Bergerh-103
• Luis F. Angelh-28